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A 73-year-old woman presented to our departmentwith a cough for 2 months. She was a housewife and had no 
history of smoking or tuberculosis, but she did have a his-
tory of significant exposure to biomass because she burned 
firewood. Chest radiograph and chest computed tomography 
showed a 2.5-cm–sized lung nodule at the left upper lung 
and percutaneous needle biopsy was performed. Pathologic 
findings suggested a pulmonary adenocarcinoma. 2-[18F] 
fluoro-2-deoxy-D-glucose (FDG)-positron emission tomog-
raphy (PET) scan showed an enlarged 1.3-cm–sized 4R LN 
(right lower paratracheal lymph node) with 4.9 standardized 
uptake value (Fig. 1A). endobronchial ultrasound-guided 
transbronchial needle aspiration was performed at 4R LN 
for a mediastinal staging. Bronchial anthracofibrosis was 
observed during bronchoscopy, (Fig. 1B) and pigmentation of 
the aspirated material was observed macroscopically during 
endobronchial ultrasound-guided transbronchial needle aspi-
ration. Left upper lobectomy was performed, and 4R LN was 
confirmed as a reactive LN with anthracosis on the resected 
lung specimen.
Bronchial anthracofibrosis (BAF) is a bronchoscopi-
cally visible anthracotic pigmentation associated with the 
narrowing or obliteration of the bronchi. BAF was previ-
ously thought to be associated with active or old tuberculosis 
infection, but it is now believed to be associated with chronic 
biomass-fuel smoke exposure.1 Mediastinal lymphadenopathy 
with calcification is common in BAF.1 False-positive PET with 
FDG as a tracer uptake in anthracosis often mimics metastatic 
lymphadenopathy seen in lung cancer.2 In conclusion, if BAF 
is found on bronchoscopy, PET scans tend to be a false-posi-
tive because of anthracosis.
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Image of the Month
FIGURE 1. A, FDG-positive emission tomography scan 
showing enlarged 4R LN with positive uptake. B, Bronchial 
anthracofibrosis of right upper lobar bronchus during 
bronchoscopy.
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